Last reviewed · How we verify
CHLORMADINONE ACETATE — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
CHLORMADINONE ACETATE (CHLORMADINONE ACETATE).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CHLORMADINONE ACETATE TARGET | CHLORMADINONE ACETATE | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CHLORMADINONE ACETATE CI watch — RSS
- CHLORMADINONE ACETATE CI watch — Atom
- CHLORMADINONE ACETATE CI watch — JSON
- CHLORMADINONE ACETATE alone — RSS
Cite this brief
Drug Landscape (2026). CHLORMADINONE ACETATE — Competitive Intelligence Brief. https://druglandscape.com/ci/chlormadinone-acetate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing